You’re not going to grow into your 2021 valuation

Share Story on

We often hear companies claim: “We will grow into our valuation from 2021.”

That statement is in reference to their expectations of when they’ll price their IPO, or with regards to a future private round. They are implying that they will wait to go public until they can price an IPO higher than or at least at the same valuation as their last funding round. This further implies that the company is opposed to down rounds or publicizing a decrease in their valuation.

Interestingly, these companies claim they can do that — as if growing into one’s 2021 valuation is easy and can happen in the near term.

We always attempt to do the math every time we hear a company make this statement (again, we hear it frequently). In most cases, pricing an IPO at a company’s 2021 valuation is more than a few years away (assuming perfect execution), and in some cases, we don’t think it will ever happen.

Our chart of the quarter depicts the math behind how long it will take companies to price their IPO so they can match their previous valuations:

Image Credits: Irving Investors

Using the chart

If you are growing slower than 30%, there is a strong chance that you will never be able to match your 2021 valuation.

The layout of the chart is meant to give every company the ability to map itself to the grid using a few metrics. The data will then tell you how long it will take a company to achieve the valuation necessary to price an IPO and match their valuation from 2021. The data ranges are generalized, but they are wide enough to be applicable to nearly every company.

Companies need three inputs to use the chart:

  1. Their own public company comparables group (guidance given below);
  2. How much that comparable group has sold off this year / CY2022 (guidance given below);
  3. Projection of your growth rate.

Step 1



Search By Category

Recent News

You May Also Like

Ahmedabad Celebrates New Retail Destination and Marks Anniversary in Style

Ahmedabad Celebrates New Retail Destination and Marks Anniversary in Style

Ahmedabad (Gujarat) [India], February 24:  Ahmedabad was in for a delicious surprise as Palladium Ahmedabad celebrated a dual milestone: the grand opening of their much-anticipated

Better health of healthcare workers in India: A Closer Look Insights by Dr. Gopal Sharan MD & CEO of TRLS Healthcare Consultancy

Better health of healthcare workers in India: A Closer Look Insights by Dr. Gopal Sharan MD & CEO of TRLS Healthcare Consultancy

New Delhi (India), February 24: In the noble profession of healthcare, where the real human touch is felt, dedicated healthcare workers render invaluable services to

Gripping poster of Gujarati movie “31st” unveiled

Gripping poster of Gujarati movie “31st” unveiled

Ahmedabad (Gujarat) [India], February 24: Excitement is mounting as the much-anticipated poster of the Gujarati film “31st” was unveiled in Ahmedabad on Wednesday, offering a tantalising

Akshaya Patra and The Breakfast Revolution Collaborate With USA Based ‘Share Our Strength’ To Impact 10,000 Children For Nutritious Meals

Akshaya Patra and The Breakfast Revolution Collaborate With USA Based ‘Share Our Strength’ To Impact 10,000 Children For Nutritious Meals

Culinary maestro Sanjeev Kapoor, and Chefs Asma Khan, Manish Mehrotra, Prateek Sadhu and Anil Rohira come together to provide a special dining experience to guests

Varmora Granito Unveils Flagship Showroom in Dewas, Madhya Pradesh

Varmora Granito Unveils Flagship Showroom in Dewas, Madhya Pradesh

Dewas (Madhya Pradesh) [India], February 24: Varmora Granito, a leading manufacturer of Tiles, Sanitaryware, and Bathware, is excited to announce the grand opening of its

Vivanza Biosciences Ltd reports Net Profit Jump of 37 per cent in 9MFY24; Total Income more than doubles to Rs. 23.50 crore

Vivanza Biosciences Ltd reports Net Profit Jump of 37 per cent in 9MFY24; Total Income more than doubles to Rs. 23.50 crore

Ahmedabad (Gujarat) [India], February 24: Gujarat based Vivanza Biosciences Ltd (BSE – 530057) – engaged in the business of pharmaceuticals and agro trading has reported